Skip to main content
Premium Trial:

Request an Annual Quote

GenOway Raises $37.4M in Alternext IPO

NEW YORK (GenomeWeb News) – GenOway, a French firm that develops transgenic mice and rats, began trading on Euronext’s Alternext exchange on April 5, the company said this week.
 
The company raised €27.7 million ($37.4 million) in its initial public offering, trading 5.6 million shares at €4.96 per share.
 
The company’s shares are trading at €6 today.
 
The Alternext, which opened two years ago, is a Euronext market designed for small and mid-cap companies.
 
GenOway develops genetically modified rat and mouse models for use in in vivo target validation and drug development.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.